{"id":130980,"date":"2024-08-13T14:32:39","date_gmt":"2024-08-13T09:02:39","guid":{"rendered":"https:\/\/tradebrains.in\/features\/?p=130980"},"modified":"2024-08-13T14:38:18","modified_gmt":"2024-08-13T09:08:18","slug":"pharma-stock-jumps-8-after-it-reports-222-yoy-net-profit-growth-in-q1","status":"publish","type":"post","link":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-8-after-it-reports-222-yoy-net-profit-growth-in-q1\/","title":{"rendered":"Pharma stock jumps 8% after it reports 222% YoY increase in net profits"},"content":{"rendered":"<div class=\"trade-content_2\" style=\"margin-left: auto;margin-right: auto;text-align: center;\" id=\"trade-3683589266\"><p><a href=\"https:\/\/tradebrains.in\/get\/telegram\/\"><img decoding=\"async\" class=\"alignnone wp-image-101992\" src=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/01\/telegram-channel-300x119.png\" alt=\"\" width=\"148\" height=\"59\" \/><\/a> <a href=\"https:\/\/news.google.com\/publications\/CAAqBwgKMN3Epgswxc--Aw?hl=en-IN&amp;gl=IN&amp;ceid=IN%3Aen\"><img decoding=\"async\" class=\"alignnone wp-image-123430\" src=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news-300x82.png\" alt=\"follow-on-google-news\" width=\"222\" height=\"61\" srcset=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news-300x82.png 300w, https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news-150x41.png 150w, https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news.png 468w\" sizes=\"(max-width: 222px) 100vw, 222px\" \/><\/a><\/p>\n<\/div><p>The shares of this pharma company gained up to 8 percent after the company\u2019s net profit and revenue increased by 222 percent and 33 percent YoY, respectively in Q1FY25.&nbsp;<\/p><div class=\"trade-content_7\" style=\"margin-left: auto;margin-right: auto;text-align: center;\" id=\"trade-3566658044\"><!-- Composite Start --> \r\n <div id=\"M923760ScriptRootC1549812\"> \r\n <\/div> \r\n <script src=\"https:\/\/jsc.mgid.com\/t\/r\/tradebrains.in.1549812.js\" async> \r\n <\/script> \r\n <!-- Composite End --><\/div><p>With a market capitalization of Rs 7,446.07 crore, the shares of <strong><a href=\"https:\/\/portal.tradebrains.in\/stock\/ORCHPHARMA\/consolidated\" target=\"_blank\" rel=\"noreferrer noopener\">Orchid Pharma Ltd<\/a><\/strong> were trading at Rs 1,468.10 per share, decreasing around 0.61 percent as compared to the previous closing price of Rs 1477.90 apiece.\u00a0<\/p><h2 class=\"wp-block-heading has-medium-font-size\"><strong>Reason for Rise:-&nbsp;<\/strong><\/h2><p>The shares of Orchid Pharma have seen such a bullish movement after revenue magnified 12 percent on a Quarter basis from Rs 217 crore in Q4FY24 to Rs 244 crore Q1FY25, if we look into the on Year on Year basis revenue magnified significantly by 33 percent from Rs 183 crore Q1FY24 to Rs 244 crore Q1FY25.&nbsp;<\/p><p>Orchid Pharma Ltd&#8217;s net profit plummeted by 12 percent on a quarter-on-quarter basis from Rs. 33 crores in Q4FY24 to Rs 29 in Q1FY25. Further, on a year-on-year basis also net profit magnified drastically by 222 percent from Rs 9 crores in Q1FY24 to Rs. 29 crores in Q1FY25.&nbsp;<\/p><div class=\"trade-content_5\" id=\"trade-1419900738\"><script async src=\"https:\/\/pagead2.googlesyndication.com\/pagead\/js\/adsbygoogle.js?client=ca-pub-4023722985638610\"\r\n     crossorigin=\"anonymous\"><\/script>\r\n<!-- in_content_2_news -->\r\n<ins class=\"adsbygoogle\"\r\n     style=\"display:block\"\r\n     data-ad-client=\"ca-pub-4023722985638610\"\r\n     data-ad-slot=\"7925020301\"\r\n     data-ad-format=\"auto\"\r\n     data-full-width-responsive=\"true\"><\/ins>\r\n<script>\r\n     (adsbygoogle = window.adsbygoogle || []).push({});\r\n<\/script><\/div><h2 class=\"wp-block-heading has-medium-font-size\"><strong>Remarkable return &amp; recent approval:-&nbsp;<\/strong><\/h2><p>The shares have been given a return of 34 percent in the period of six months and a multi-bagger return of 164 percent in 1 year. If an individual invested Rs 1 lakh a year ago it will be worth it now Rs 2.65 lakh.&nbsp;<\/p><p>Orchid Pharma&#8217;s innovative medicine Enmetazobactam was authorized in both the United States and Europe in Q4 FY23-24 and will be marketed soon, a significant success for India because it is the first drug created in India to attain this milestone.&nbsp;<\/p><h2 class=\"wp-block-heading has-medium-font-size\"><strong>Ratio analysis:-&nbsp;<\/strong><\/h2><p>Examining the company\u2019s crucial ratio, return on equity inclined from 6.72 percent in FY22-23 to 7.88 percent in FY23-24, while during the same time frame return on capital employed also inclined from 5.65 percent to 8.37 percent. In contrast, the net profit margin (NPM) stands at 11.60 percent in fiscal year 23-24.&nbsp;<\/p><blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\"><p><strong>Also Read<\/strong><\/p>\n\n<figure class=\"wp-block-embed is-type-wp-embed is-provider-trade-brains wp-block-embed-trade-brains\"><div class=\"wp-block-embed__wrapper\">\n<blockquote class=\"wp-embedded-content\" data-secret=\"9lxUGs9ryv\"><a href=\"https:\/\/tradebrains.in\/features\/dolly-khanna-stock-hits-10-upper-circuit-after-reporting-75-yoy-increase-in-net-profits\/\">Dolly Khanna stock hits 10% upper circuit after reporting 75% YoY increase in net profits<\/a><\/blockquote><iframe class=\"wp-embedded-content\" sandbox=\"allow-scripts\" security=\"restricted\" style=\"position: absolute; visibility: hidden;\" title=\"&#8220;Dolly Khanna stock hits 10% upper circuit after reporting 75% YoY increase in net profits&#8221; &#8212; Trade Brains\" src=\"https:\/\/tradebrains.in\/features\/dolly-khanna-stock-hits-10-upper-circuit-after-reporting-75-yoy-increase-in-net-profits\/embed\/#?secret=CVrKBTfTmv#?secret=9lxUGs9ryv\" data-secret=\"9lxUGs9ryv\" width=\"600\" height=\"338\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\"><\/iframe>\n<\/div><\/figure><\/blockquote><h2 class=\"wp-block-heading has-medium-font-size\"><strong>Company profile:-&nbsp;<\/strong><\/h2><p>Orchid Pharma Limited manufactures integrated active medicinal components. It operates in the pharmaceutical sector. It has several therapeutic applications, including anti-infectives, anti-inflammatory, CNS, CVS, nutraceuticals, and oral\/sterile products.&nbsp;<\/p><blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\"><p><strong>Written by:- Abhishek Singh<\/strong><\/p>\n\n<h4 class=\"wp-block-heading\" id=\"h-disclaimer\"><strong>Disclaimer<\/strong><\/h4>\n\n<div class=\"wp-block-image\"><figure class=\"aligncenter size-medium\"><img decoding=\"async\" width=\"300\" height=\"300\" src=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2022\/02\/warning-disclaimer-300x300.png\" alt=\"\" class=\"wp-image-26306\"\/><\/figure><\/div>\n\n<p><strong>The views and investment tips expressed by investment experts\/broking houses\/rating agencies on <a href=\"http:\/\/tradebrains.in\/\">tradebrains.in<\/a> are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Dailyraven Technologies or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing<\/strong>.<\/p><\/blockquote><div class=\"trade-after-content\" id=\"trade-6640910\"><div id=\"taboola-below-article-thumbnails\"><\/div>\r\n<script type=\"text\/javascript\">\r\n  window._taboola = window._taboola || [];\r\n  _taboola.push({\r\n    mode: 'alternating-thumbnails-a',\r\n    container: 'taboola-below-article-thumbnails',\r\n    placement: 'Below Article Thumbnails',\r\n    target_type: 'mix'\r\n  });\r\n<\/script>\r\n<script type=\"text\/javascript\">\r\n  window._taboola = window._taboola || [];\r\n  _taboola.push({flush: true});\r\n<\/script><\/div>","protected":false},"excerpt":{"rendered":"<p>The shares of this pharma company gained up to 8 percent after the company\u2019s net profit and revenue increased by 222 percent and 33 percent YoY, respectively in Q1FY25.&nbsp; With a market capitalization of Rs 7,446.07 crore, the shares of Orchid Pharma Ltd were trading at Rs 1,468.10 per share, decreasing around 0.61 percent as [&hellip;]<\/p>\n","protected":false},"author":5,"featured_media":98971,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"categories":[31,1789],"tags":[18516,13892,10344,6616,948,936,3157],"class_list":["post-130980","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","category-trending-news","tag-orchid-pharma","tag-orchid-pharma-latest-news","tag-orchid-pharma-share-price","tag-pharma-stock","tag-stock-market","tag-stock-market-news","tag-stock-to-watch"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v20.5 (Yoast SEO v25.0) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Pharma stock jumps 8% after it reports 222% YoY increase in net profits - Trade Brains Features<\/title>\n<meta name=\"description\" content=\"The shares of this pharma company gained up to 8 percent after the company\u2019s net profit and revenue increased by 222 percent and 33 percent YoY, respectively in Q1FY25.\u00a0\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-8-after-it-reports-222-yoy-net-profit-growth-in-q1\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Pharma stock jumps 8% after it reports 222% YoY increase in net profits\" \/>\n<meta property=\"og:description\" content=\"The shares of this pharma company gained up to 8 percent after the company\u2019s net profit and revenue increased by 222 percent and 33 percent YoY, respectively in Q1FY25.\u00a0\" \/>\n<meta property=\"og:url\" content=\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-8-after-it-reports-222-yoy-net-profit-growth-in-q1\/\" \/>\n<meta property=\"og:site_name\" content=\"Trade Brains Features\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/TradeBrainsOfficial\/\" \/>\n<meta property=\"article:published_time\" content=\"2024-08-13T09:02:39+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-08-13T09:08:18+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/04\/pharma-cover-image.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1280\" \/>\n\t<meta property=\"og:image:height\" content=\"854\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Trade Brains\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@TradeBrainsGrp\" \/>\n<meta name=\"twitter:site\" content=\"@TradeBrainsGrp\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Trade Brains\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-8-after-it-reports-222-yoy-net-profit-growth-in-q1\/\",\"url\":\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-8-after-it-reports-222-yoy-net-profit-growth-in-q1\/\",\"name\":\"Pharma stock jumps 8% after it reports 222% YoY increase in net profits - Trade Brains Features\",\"isPartOf\":{\"@id\":\"https:\/\/tradebrains.in\/features\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-8-after-it-reports-222-yoy-net-profit-growth-in-q1\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-8-after-it-reports-222-yoy-net-profit-growth-in-q1\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/04\/pharma-cover-image.jpg\",\"datePublished\":\"2024-08-13T09:02:39+00:00\",\"dateModified\":\"2024-08-13T09:08:18+00:00\",\"author\":{\"@id\":\"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666\"},\"description\":\"The shares of this pharma company gained up to 8 percent after the company\u2019s net profit and revenue increased by 222 percent and 33 percent YoY, respectively in Q1FY25.\u00a0\",\"breadcrumb\":{\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-8-after-it-reports-222-yoy-net-profit-growth-in-q1\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-8-after-it-reports-222-yoy-net-profit-growth-in-q1\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-8-after-it-reports-222-yoy-net-profit-growth-in-q1\/#primaryimage\",\"url\":\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/04\/pharma-cover-image.jpg\",\"contentUrl\":\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/04\/pharma-cover-image.jpg\",\"width\":1280,\"height\":854},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-8-after-it-reports-222-yoy-net-profit-growth-in-q1\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/tradebrains.in\/features\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Pharma stock jumps 8% after it reports 222% YoY increase in net profits\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/tradebrains.in\/features\/#website\",\"url\":\"https:\/\/tradebrains.in\/features\/\",\"name\":\"Trade Brains\",\"description\":\"Stock Market NSE\/BSE Latest News\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/tradebrains.in\/features\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666\",\"name\":\"Trade Brains\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/tradebrains.in\/features\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g\",\"caption\":\"Trade Brains\"},\"sameAs\":[\"http:\/\/tradebrains.in\/\"],\"url\":\"https:\/\/tradebrains.in\/features\/author\/trade-brains\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Pharma stock jumps 8% after it reports 222% YoY increase in net profits - Trade Brains Features","description":"The shares of this pharma company gained up to 8 percent after the company\u2019s net profit and revenue increased by 222 percent and 33 percent YoY, respectively in Q1FY25.\u00a0","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-8-after-it-reports-222-yoy-net-profit-growth-in-q1\/","og_locale":"en_US","og_type":"article","og_title":"Pharma stock jumps 8% after it reports 222% YoY increase in net profits","og_description":"The shares of this pharma company gained up to 8 percent after the company\u2019s net profit and revenue increased by 222 percent and 33 percent YoY, respectively in Q1FY25.\u00a0","og_url":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-8-after-it-reports-222-yoy-net-profit-growth-in-q1\/","og_site_name":"Trade Brains Features","article_publisher":"https:\/\/www.facebook.com\/TradeBrainsOfficial\/","article_published_time":"2024-08-13T09:02:39+00:00","article_modified_time":"2024-08-13T09:08:18+00:00","og_image":[{"width":1280,"height":854,"url":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/04\/pharma-cover-image.jpg","type":"image\/jpeg"}],"author":"Trade Brains","twitter_card":"summary_large_image","twitter_creator":"@TradeBrainsGrp","twitter_site":"@TradeBrainsGrp","twitter_misc":{"Written by":"Trade Brains","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-8-after-it-reports-222-yoy-net-profit-growth-in-q1\/","url":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-8-after-it-reports-222-yoy-net-profit-growth-in-q1\/","name":"Pharma stock jumps 8% after it reports 222% YoY increase in net profits - Trade Brains Features","isPartOf":{"@id":"https:\/\/tradebrains.in\/features\/#website"},"primaryImageOfPage":{"@id":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-8-after-it-reports-222-yoy-net-profit-growth-in-q1\/#primaryimage"},"image":{"@id":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-8-after-it-reports-222-yoy-net-profit-growth-in-q1\/#primaryimage"},"thumbnailUrl":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/04\/pharma-cover-image.jpg","datePublished":"2024-08-13T09:02:39+00:00","dateModified":"2024-08-13T09:08:18+00:00","author":{"@id":"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666"},"description":"The shares of this pharma company gained up to 8 percent after the company\u2019s net profit and revenue increased by 222 percent and 33 percent YoY, respectively in Q1FY25.\u00a0","breadcrumb":{"@id":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-8-after-it-reports-222-yoy-net-profit-growth-in-q1\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/tradebrains.in\/features\/pharma-stock-jumps-8-after-it-reports-222-yoy-net-profit-growth-in-q1\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-8-after-it-reports-222-yoy-net-profit-growth-in-q1\/#primaryimage","url":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/04\/pharma-cover-image.jpg","contentUrl":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/04\/pharma-cover-image.jpg","width":1280,"height":854},{"@type":"BreadcrumbList","@id":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-8-after-it-reports-222-yoy-net-profit-growth-in-q1\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/tradebrains.in\/features\/"},{"@type":"ListItem","position":2,"name":"Pharma stock jumps 8% after it reports 222% YoY increase in net profits"}]},{"@type":"WebSite","@id":"https:\/\/tradebrains.in\/features\/#website","url":"https:\/\/tradebrains.in\/features\/","name":"Trade Brains","description":"Stock Market NSE\/BSE Latest News","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/tradebrains.in\/features\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666","name":"Trade Brains","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/tradebrains.in\/features\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g","caption":"Trade Brains"},"sameAs":["http:\/\/tradebrains.in\/"],"url":"https:\/\/tradebrains.in\/features\/author\/trade-brains\/"}]}},"_links":{"self":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts\/130980","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/comments?post=130980"}],"version-history":[{"count":3,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts\/130980\/revisions"}],"predecessor-version":[{"id":130986,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts\/130980\/revisions\/130986"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/media\/98971"}],"wp:attachment":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/media?parent=130980"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/categories?post=130980"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/tags?post=130980"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}